Geographic EBV variants confound disease-specific variant interpretation and predict variable immune therapy responses

Authors: Briercheck, Edward L., Ravishankar, Shashidhar, Ahmed, Elshafa Hassan, Carías Alvarado, César Camilo, Barrios Menéndez, Juan Carlos, Silva, Oscar, Solórzano-Ortiz, Elizabeth, Siliézar Tala, Marcos Mauricio, Stevenson, Philip, Xu, Yuexin, Wohns, Anthony Wilder, Enriquez-Vera, Daniel, Barrionuevo, Carlos, Yu, Shan-Chi, Freud, Aharon G., Oakes, Christopher, Weigel, Christoph, Weinstock, David M., Klimaszewski, Haley L., Ngankeu, Apollinaire, Mutalima, Nora, Samayoa-Reyes, Gabriela, Newton, Robert, Rochford, Rosemary, Valvert, Fabiola, Natkunam, Yasodha, Shustov, Andrei, Baiocchi, Robert A., Warren, Edus H.

Source: In Blood Advances 23 July 2024 8(14):3731-3744

Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia

Authors: Cassaday, Ryan D., Zarling, Lucas C., Garcia, Kelsey-Leigh A., Sala-Torra, Olga, Stevenson, Philip A., Martino, Christen H., Liu, Yajuan J., Fang, Min, Percival, Mary-Elizabeth M., Halpern, Anna B., Becker, Pamela S., Oehler, Vivian G., Shustov, Andrei R., Cooper, Jason P., Orozco, Johnnie J., Hendrie, Paul C., Walter, Roland B., Radich, Jerald P., Soma, Lorinda A., Estey, Elihu H.

Source: Leukemia & lymphoma. 64(5):927-937

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100190362871.0x000001&indx=1&recIds=ETOCvdc_100190362871.0x000001

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

Authors: Savage, Kerry J., Horwitz, Steven M., Advani, Ranjana, Christensen, Jacob Haaber, Domingo-Domenech, Eva, Rossi, Giuseppe, Morschhauser, Franck, Alpdogan, Onder, Suh, Cheolwon, Tobinai, Kensei, Shustov, Andrei, Trneny, Marek, Yuen, Sam, Zinzani, Pier Luigi, Trümper, Lorenz, Ilidge, Tim, O’Connor, Owen A., Pro, Barbara, Miao, Harry, Bunn, Veronica, Fenton, Keenan, Fanale, Michelle, Puhlmann, Markus, Iyer, Swaminathan

Source: In Blood Advances 11 October 2022 6(19):5550-5555

Cerebrospinal fluid flow cytometry and risk of central nervous system relapse after hyperCVAD in adults with acute lymphoblastic leukemia

Authors: Garcia, Kelsey‐Leigh A., Cherian, Sindhu, Stevenson, Philip A., Martino, Christen H., Shustov, Andrei R., Becker, Pamela S., Percival, Mary‐Elizabeth M., Oehler, Vivian G., Halpern, Anna B., Walter, Roland B., Orozco, Johnnie J., Keel, Siobán B., Estey, Elihu H., Cassaday, Ryan D.

Source: Cancer. 128(7):1411-1417

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100144654342.0x000001&indx=1&recIds=ETOCvdc_100144654342.0x000001

Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a multicentre, phase 1 study

Authors: Querfeld, Christiane ^*, Thompson, John A, Taylor, Matthew H, DeSimone, Jennifer A, Zain, Jasmine M, Shustov, Andrei R, Johns, Carolyn, McCann, Sue, Lin, Gloria H Y, Petrova, Penka S, Uger, Robert A, Molloy, Naomi, Shou, Yaping, Akilov, Oleg E

Source: In The Lancet Haematology November 2021 8(11):e808-e817

Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study

Authors: Lynch, Ryan C, Cassaday, Ryan D, Smith, Stephen D, Fromm, Jonathan R, Cowan, Andrew J, Warren, Edus H, Shadman, Mazyar S, Shustov, Andrei, Till, Brian G, Ujjani, Chaitra S, Libby, Edward N, III, Philip, Mary, Coye, Hilary, Martino, Christen N, Bhark, Sandra L, Morris, Karolyn, Rasmussen, Heather, Behnia, Sanaz, Voutsinas, Jenna, Gopal, Ajay K ^*

Source: In The Lancet Haematology August 2021 8(8):e562-e571

Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project

Authors: Advani, Ranjana H. ^*, Skrypets, Tetiana, Civallero, Monica, Spinner, Michael A., Manni, Martina, Kim, Won Seog, Shustov, Andrei R., Horwitz, Steven M., Hitz, Felicitas, Cabrera, Maria Elena, Dlouhy, Ivan, Vassallo, José, Pileri, Stefano A., Inghirami, Giorgio, Montoto, Silvia, Vitolo, Umberto, Radford, John, Vose, Julie M., Federico, Massimo

Source: In Blood 22 July 2021 138(3):213-220

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study

Authors: Falchi, Lorenzo ^*, Ma, Helen ^*, Klein, Sandra, Lue, Jennifer K., Montanari, Francesca, Marchi, Enrica, Deng, Changchun, Kim, Hye A., Rada, Aishling, Jacob, Alice T., Kinahan, Cristina, Francescone, Mark M., Soderquist, Craig R., Park, David C., Bhagat, Govind, Nandakumar, Renu, Menezes, Daniel, Scotto, Luigi, Sokol, Lubomir, Shustov, Andrei R., O'Connor, Owen A. ^*

Source: In Blood 22 April 2021 137(16):2161-2170

ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project

Authors: Shustov, Andrei, Cabrera, Maria Elena, Civallero, Monica, Bellei, Monica, Ko, Young Hyeh, Manni, Martina, Skrypets, Tetiana, Horwitz, Steven M., De Souza, Carmino Antonio, Radford, John A., Bobillo, Sabela, Prates, Maria Virginia, Ferreri, Andrés J.M., Chiattone, Carlos, Spina, Michele, Vose, Julie M., Chiappella, Annalisa, Laszlo, Daniele, Marino, Dario, Stelitano, Caterina, Federico, Massimo

Source: In Blood Advances 9 February 2021 5(3):640-648

Outcomes of Patients with Transformed Mycosis Fungoides: Analysis from a Prospective Multicenter US Cohort Study

Authors: Lansigan, Frederick, Horwitz, Steven M., Pinter-Brown, Lauren C., Carson, Kenneth R., Shustov, Andrei R., Rosen, Steven T., Pro, Barbara, Hsi, Eric D., Federico, Massimo, Gisselbrecht, Christian, Schwartz, Marc, Bellm, Lisa A., Acosta, Mark, Foss, Francine M.

Source: In Clinical Lymphoma, Myeloma and Leukemia November 2020 20(11):744-748

Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project

Authors: Fox, Christopher P, Civallero, Monica, Ko, Young-Hyeh, Manni, Martina, Skrypets, Tetiana, Pileri, Stefano, Kim, Seok Jin, Cabrera, Maria Elena, Shustov, Andrei R, Chiattone, Carlos S, Horwitz, Steven M, Dlouhy, Ivan, Spina, Michele, Hitz, Felicitas, Montoto, Silvia, Nagler, Arnon, Martinez, Virginia, De Souza, Carmino A, Fernandez-Alvarez, Ruben, Ballova, Veronika, Gabús, Raul, Inghirami, Giorgio, Federico, Massimo, Kim, Won Seog ^*

Source: In The Lancet Haematology April 2020 7(4):e284-e294

Oral 5-azacytidine and romidepsin exhibit marked activity in patients with PTCL: a multicenter phase 1 study

Authors: O'Connor, Owen A., Falchi, Lorenzo, Lue, Jennifer K., Marchi, Enrica, Kinahan, Cristina, Sawas, Ahmed, Deng, Changchun, Montanari, Francesca, Amengual, Jennifer E., Kim, Hye A., Rada, Aishling M., Khan, Karen, Jacob, Alice T., Malanga, Michelle, Francescone, Mark M., Nandakumar, Renu, Soderquist, Craig R., Park, David C., Bhagat, Govind, Cheng, Bin, Risueño, Alberto, Menezes, Daniel, Shustov, Andrei R., Sokol, Lubomir, Scotto, Luigi

Source: In Blood 24 October 2019 134(17):1395-1405

Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia

Authors: Staber, Philipp B. ^*, Herling, Marco, Bellido, Mar, Jacobsen, Eric D., Davids, Matthew S., Kadia, Tapan Mahendra, Shustov, Andrei, Tournilhac, Olivier, Bachy, Emmanuel, Zaja, Francesco, Porkka, Kimmo, Hoermann, Gregor, Simonitsch-Klupp, Ingrid, Haferlach, Claudia, Kubicek, Stefan, Mayerhoefer, Marius E., Hopfinger, Georg, Jaeger, Ulrich, Dearden, Claire

Source: In Blood 3 October 2019 134(14):1132-1143

How I treat primary cutaneous CD30+ lymphoproliferative disorders

Authors: Shinohara, Michi M. ^*, Shustov, Andrei ^*

Source: In Blood 8 August 2019 134(6):515-524

Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience

Authors: Cooper, Jason P., Khajaviyan, Sirin, Smith, Stephen D., Maloney, David G., Shustov, Andrei R., Warren, Edus H., Soma, Lorinda A., Lynch, Ryan C., Ujjani, Chaitra, Till, Brian, Halpern, Anna B., Gopal, Ajay K., Deeg, H. Joachim, Scott, Bart L., Shadman, Mazyar

Source: In Clinical Lymphoma, Myeloma and Leukemia June 2019 19(6):390-395

Pembrolizumab with R‐CHOP in previously untreated diffuse large B‐cell lymphoma: potential for biomarker driven therapy

Authors: Smith, Stephen D., Till, Brian G., Shadman, Mazyar S., Lynch, Ryan C., Cowan, Andrew J., Wu, Qian V., Voutsinas, Jenna, Rasmussen, Heather A., Blue, Katherine, Ujjani, Chaitra S., Shustov, Andrei, Cassaday, Ryan D., Fromm, Jonathan R., Gopal, Ajay K.

Source: British journal of haematology. 189(6):1119-1126

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100124256238.0x000001&indx=1&recIds=ETOCvdc_100124256238.0x000001

Characterizing the belinostat response in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma

Authors: Sawas, Ahmed, Ma, Helen, Shustov, Andrei, Hsu, Pamela, Bhat, Gajanan, Acosta, Mark, Horwitz, Steven, O'Connor, Owen A.

Source: Leukemia & lymphoma. 61(8):2003-2007

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100110727679.0x000001&indx=1&recIds=ETOCvdc_100110727679.0x000001

Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry

Authors: Lansigan, Frederick, Horwitz, Steven M., Pinter-Brown, Lauren C., Rosen, Steven T., Pro, Barbara, Hsi, Eric D., Federico, Massimo, Gisselbrecht, Christian, Schwartz, Marc, Bellm, Lisa A., Acosta, Mark, Shustov, Andrei R., Advani, Ranjana H., Feldman, Tatyana, Lechowicz, Mary Jo, Smith, Sonali M., Tulpule, Anil, Craig, Michael D., Greer, John P., Kahl, Brad S., Leach, Joseph W., Morganstein, Neil, Casulo, Carla, Park, Steven I., Foss, Francine M.

Source: Acta haematologica. 143(1):40-50

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100097147017.0x000001&indx=1&recIds=ETOCvdc_100097147017.0x000001

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Authors: Aboulafia, David, Advani, Ranjana, Alpdogan, Onder, Ando, Kiyoshi, Arcaini, Luca, Baldini, Luca, Bellam, Naresh, Bartlett, Nancy, Belada, David, Yehuda, Dina Ben, Benedetti, Fabio, Borchman, Peter, Bordessoule, Dominique, Brice, Pauline, Briones, Javier, Caballero, Dolores, Carella, Angelo Michele, Chang, Hung, Cheong, June Weon, Cho, Seok-Goo, Choi, Ilseung, Choquet, Sylvain, Colita, Andrei, Congui, Angela Giovanna, D'amore, Francesco, Dang, Nam, Davison, Kelly, de Guibert, Sophie, Brown, Peter de Nully, Delwail, Vincent, Demeter, Judit, di Raimondo, Francesco, Do, Young Rok, Domingo, Eva, Douvas, Michael, Dreyling, Martin, Ernst, Thomas, Fanale, Michelle, Fay, Keith, Feldman, Tatyana, Ferrero, Silvia Fernandez, Flinn, Ian Winchester, Forero-Torres, Andres, Fox, Christopher, Friedberg, Jonathan, Fukuhara, Noriko, Garcia-Marco, Jose, Cruz, Jorge Gayoso, Codina, Jose Gomez, Gressin, Remy, Grigg, Andrew, Gurion, Ronit, Christensen, Jacob Haaber, Haioun, Corinne, Hajek, Roman, Hanel, Mathias, Hatake, Kiyohiko, Hensen, Robert, Horowitz, Netanel, Horwitz, Steven, Huttmann, Andreas, Illes, Arpad, Illidge, Tim, Ishizawa, Kenichi, Islas-Ohlmayer, Miguel, Jacobsen, Eric, Janakiram, Murali, Jurczak, Wojciech, Kaminski, Mark, Kato, Koji, Kim, Won Seog, Kirgner, Ilya, Iyer, Swaminathan, Kuo, Ching-Yuan, Lazaroiu, Mihaela Cornelia, Du, Katell Le, Lee, Jong-Seok, LeGouill, Steven, Lennard, Anne, LaRosee, Paul, Levi, Itai, Link, Brian, Maisonneuve, Herve, Maruyama, Dai, Mayer, Jiri, McCarty, John, McKay, Pam, Minami, Yosuke, Mocikova, Heidi, Morra, Enrica, Morschhauser, Franck, Munoz, Javier, Nagai, Hirokazu, O'Connor, Owen, Opat, Stephen, Pettengell, Ruth, Pezzutto, Antonio, Pfreundschuh, Michael, Pluta, Andrzej, Porcu, PierLuigi, Pro, Barbara, Quach, Hang, Rambaldi, Alessandro, Renwick, William, Reyes, Ruben, Izquierdo, Antonia Rodriguez, Rossi, Giuseppe, Ruan, Jia, Rusconi, Chiara, Salles, Gilles, Santoro, Armando, Sarriera, Jose, Savage, Kerry, Shibayama, Hirohiko, Shustov, Andrei, Suh, Cheolwon, Sureda, Anna, Tanimoto, Mitsune, Taniwaki, Masafumi, Tilly, Herve, Tobinai, Kensei, Trneny, Marek, Trumper, Lorenz, Tsukamoto, Norifumi, Tsukasaki, Kunihiro, Vitolo, Umberto, Walewski, Jan, Weidmann, Eckhart, Wilhelm, Martin, Witzens-Harig, Mathias, Yacoub, Abdulraheem, Yamamoto, Kazuhito, Yeh, Su-Peng, Yoon, Sung-Soo, Yuen, Sam, Yun, Hwan Jung, Zain, Jasmine, Zinzani, Pier Luigi, O'Connor, Owen A, Bartlett, Nancy L, Domingo-Domenech, Eva, Illés, Árpád, Hüttmann, Andreas, Savage, Kerry J, Hua, Zhaowei, Little, Meredith, Rao, Shangbang, Woolery, Joseph, Manley, Thomas, Trümper, Lorenz

Source: In The Lancet 19-25 January 2019 393(10168):229-240

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Authors: Abhyankar, Sunil, Akilov, Oleg, Alpdogan, Onder, Beylot-Barry, Marie, Boh, Erin, Caballero, Dolores, Cowan, Richard, Dreno, Brigitte, Dummer, Reinhard, Fenske, Timothy, Foss, Francine, Fukuhara, Noriko, Giri, Pratyush, Habe, Koji, Hamada, Toshihisa, Hatake, Kiyohiko, Iida, Shinsuke, Ishikawa, Osamu, Iversen, Lars, Kiyohara, Eiji, Koga, Hiroshi, Korman, Neil, Kuss, Bryone Jean, Lamar, Zanetta, Lansigan, Frederick, Lechowicz, Mary Jo, Lerner, Adam, Magnolo, Nina, Mark, Lawrence, Miyagaki, Tomomitsu, Munoz, Javier, Nicolay, Jan Peter, Nishiwaki, Kaoru, Okamoto, Hiroyuki, Ohtsuka, Mikio, Pacheco, Theresa, Querfeld, Christiane, Rapini, Ronald Peter, Sano, Shigetoshi, Tanaka, Maiko, Tharp, Michael D., Uehara, Jiro, Wada, Hidefumi, Wells, Jillian, Wilcox, Ryan A., William, Basem, Yonekura, Kentaro, Kim, Youn H, Bagot, Martine, Pinter-Brown, Lauren, Rook, Alain H, Porcu, Pierluigi, Horwitz, Steven M, Whittaker, Sean, Tokura, Yoshiki, Vermeer, Maarten, Zinzani, Pier Luigi, Sokol, Lubomir, Morris, Stephen, Kim, Ellen J, Ortiz-Romero, Pablo L, Eradat, Herbert, Scarisbrick, Julia, Tsianakas, Athanasios, Elmets, Craig, Dalle, Stephane, Fisher, David C, Halwani, Ahmad, Poligone, Brian, Greer, John, Fierro, Maria Teresa, Khot, Amit, Moskowitz, Alison J, Musiek, Amy, Shustov, Andrei, Pro, Barbara, Geskin, Larisa J, Dwyer, Karen, Moriya, Junji, Leoni, Mollie, Humphrey, Jeffrey S, Hudgens, Stacie, Grebennik, Dmitri O, Tobinai, Kensei, Duvic, Madeleine

Source: In The Lancet Oncology September 2018 19(9):1192-1204